The Evaluation and Management of Adult Intracerebral Hemorrhage

Xuemei Cai; Jonathan Rosand

doi:10.1055/s-0035-1564687

Seminars in Neurology, Table of Contents

Semin Neurol 2015; 35(06): 638-645
DOI: 10.1055/s-0035-1564687

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Evaluation and Management of Adult Intracerebral Hemorrhage

Xuemei Cai

¹Division of Neurocritical Care and Emergency Neurology, Division of Neurocritical Care and Emergency Neurology, Massachusetts General Hospital, Boston, Massachusetts

,

Jonathan Rosand

²Division of Neurocritical Care and Emergency Neurology, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts

› Author Affiliations

Abstract

Intracerebral hemorrhage (ICH) is the most disabling and deadly form of stroke. Although mortality remains high, new data suggest that outcomes can be improved with standardized medical care. In this review, the authors outline the most up-to-date knowledge, including the results of the latest phase III clinical trials on the specialized care needed to treat patients with ICH. They provide an overview on how to achieve rapid diagnosis and the initial steps of intervention to reduce hematoma volume or prevent expansion by modifying potentially treatable conditions, such as underlying vascular etiologies, blood pressure control, and coagulopathies. Grading scales can help identify patients at risk for hematoma expansion and functional disabilities and guide clinical decision making. Other medical management topics important to recovery and prevention of secondary brain injury include seizure prevention and treatment, glycemic control, temperature control, and deep venous thrombosis prophylaxis and treatment. Treatment options in surgery are also possible in select patients; there are emerging studies regarding minimally invasive surgery for the management of ICH. These aggressive therapies are essential to lower the morbidity and mortality of patients presenting with ICH.

Keywords

intracerebral hemorrhage - diagnosis - treatment - coagulopathy - surgery

Full Text

References

References
1 Sudlow CL, Warlow CP ; International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 1997; 28 (3) 491-499
2 Flaherty ML, Haverbusch M, Sekar P , et al. Long-term mortality after intracerebral hemorrhage. Neurology 2006; 66 (8) 1182-1186
3 Sakamoto Y, Koga M, Yamagami H , et al; SAMURAI Study Investigators. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke 2013; 44 (7) 1846-1851
4 Anderson CS, Heeley E, Huang Y , et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368 (25) 2355-2365
5 Mould WA, Carhuapoma JR, Muschelli J , et al; MISTIE Investigators. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke 2013; 44 (3) 627-634
6 Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM ; STICH II Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 2013; 382 (9890) 397-408
7 Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001; 29 (3) 635-640
8 Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol 2001; 13 (2) 83-92
9 van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010; 9 (2) 167-176
10 Flaherty ML, Woo D, Haverbusch M , et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005; 36 (5) 934-937
11 Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344 (19) 1450-1460
12 Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 1986; 17 (6) 1078-1083
13 Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993; 43 (10) 2073-2079
14 Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 1971; 30 (3) 536-550
15 Greenberg SM. Amyloid angiopathy. Neurology 1997; 48 (1) 291
16 Samarasekera N, Fonville A, Lerpiniere C , et al; Lothian Audit of the Treatment of Cerebral Haemorrhage Collaborators. Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study. Stroke 2015; 46 (2) 361-368
17 Fan JS, Huang HH, Chen YC , et al. Emergency department neurologic deterioration in patients with spontaneous intracerebral hemorrhage: incidence, predictors, and prognostic significance. Acad Emerg Med 2012; 19 (2) 133-138
18 Caplan LR. Intracerebral hemorrhage. In: Caplan LR, , ed. Caplan's Stroke: A Clinical Approach. 3rd ed. Boston: Butterworth-Heinemann; 2000
19 Broderick JP, Brott TG, Tomsick T, Barsan W, Spilker J. Ultra-early evaluation of intracerebral hemorrhage. J Neurosurg 1990; 72 (2) 195-199
20 Smith EE, Rosand J, Greenberg SM. Hemorrhagic stroke. Neuroimaging Clin N Am 2005; 15 (2) 259-272 , ix ix
21 Huttner HB, Steiner T, Hartmann M , et al. Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke 2006; 37 (2) 404-408
22 Kothari RU, Brott T, Broderick JP , et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27 (8) 1304-1305
23 Laissy JP, Normand G, Monroc M, Duchateau C, Alibert F, Thiebot J. Spontaneous intracerebral hematomas from vascular causes. Predictive value of CT compared with angiography. Neuroradiology 1991; 33 (4) 291-295
24 Cai X, Han S, Feske SK, Chou SH. Pearls and oy-sters: small but consequential: intracerebral hemorrhage caused by lenticulostriate artery aneurysm. Neurology 2013; 80 (9) e89-e91
25 Hino A, Fujimoto M, Yamaki T, Iwamoto Y, Katsumori T. Value of repeat angiography in patients with spontaneous subcortical hemorrhage. Stroke 1998; 29 (12) 2517-2521
26 Davis SM, Broderick J, Hennerici M , et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66 (8) 1175-1181
27 Brouwers HB, Chang Y, Falcone GJ , et al. Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol 2014; 71 (2) 158-164
28 Wang X, Arima H, Al-Shahi Salman R , et al; INTERACT Investigators. Clinical prediction algorithm (BRAIN) to determine risk of hematoma growth in acute intracerebral hemorrhage. Stroke 2015; 46 (2) 376-381
29 Goldstein JN, Fazen LE, Snider R , et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology 2007; 68 (12) 889-894
30 Wada R, Aviv RI, Fox AJ , et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 2007; 38 (4) 1257-1262
31 Delgado Almandoz JE, Yoo AJ, Stone MJ , et al. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke 2010; 41 (1) 54-60
32 Huynh TJ, Demchuk AM, Dowlatshahi D , et al; PREDICT/Sunnybrook ICH CTA Study Group. Spot sign number is the most important spot sign characteristic for predicting hematoma expansion using first-pass computed tomography angiography: analysis from the PREDICT study. Stroke 2013; 44 (4) 972-977
33 Wijman CA, Venkatasubramanian C, Bruins S, Fischbein N, Schwartz N. Utility of early MRI in the diagnosis and management of acute spontaneous intracerebral hemorrhage. Cerebrovasc Dis 2010; 30 (5) 456-463
34 Fogelholm R, Avikainen S, Murros K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 1997; 28 (7) 1396-1400
35 Rodriguez-Luna D, Piñeiro S, Rubiera M , et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol 2013; 20 (9) 1277-1283
36 Qureshi AI, Palesch YY. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care 2011; 15 (3) 559-576
37 Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology 2003; 61 (10) 1351-1356
38 Schwarz S, Häfner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000; 54 (2) 354-361
39 Rincon F, Lyden P, Mayer SA. Relationship between temperature, hematoma growth, and functional outcome after intracerebral hemorrhage. Neurocrit Care 2013; 18 (1) 45-53
40 Kollmar R, Staykov D, Dörfler A, Schellinger PD, Schwab S, Bardutzky J. Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke 2010; 41 (8) 1684-1689
41 Broessner G, Beer R, Lackner P , et al. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke 2009; 40 (12) e657-e665
42 Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil 2003; 82 (5) 364-369
43 Lacut K, Bressollette L, Le Gal G , et al; VICTORIAh (Venous Intermittent Compression and Thrombosis Occurrence Related to Intra-cerebral Acute hemorrhage) Investigators. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005; 65 (6) 865-869
44 Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G ; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet 2013; 382 (9891) 516-524
45 Hemphill III JC, Greenberg SM, Anderson CS , et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46 (7) 2032-2060
46 Paciaroni M, Agnelli G, Venti M, Alberti A, Acciarresi M, Caso V. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost 2011; 9 (5) 893-898
47 Prabhakaran S, Herbers P, Khoury J , et al. Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage?. Stroke 2015; 46 (2) 369-375
48 Kelly J, Hunt BJ, Lewis RR, Rudd A. Anticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism?. Stroke 2003; 34 (12) 2999-3005
49 Guyatt GH, Akl EA, Crowther M , et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: 7S-47S
50 Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002; 43 (10) 1175-1180
51 Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004; 62 (10) 1743-1748
52 Vespa PM, O'Phelan K, Shah M , et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003; 60 (9) 1441-1446
53 Naidech AM, Garg RK, Liebling S , et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke 2009; 40 (12) 3810-3815
54 Messé SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE ; CHANT investigators. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care 2009; 11 (1) 38-44
55 Gilad R, Boaz M, Dabby R, Sadeh M, Lampl Y. Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment?. Epilepsy Res 2011; 95 (3) 227-231
56 Ott KH, Kase CS, Ojemann RG, Mohr JP. Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases. Arch Neurol 1974; 31 (3) 160-167
57 Heros RC. Cerebellar hemorrhage and infarction. Stroke 1982; 13 (1) 106-109
58 Zumkeller M, Höllerhage HG, Pröschl M, Dietz H. The results of surgery for intracerebral hematomas. Neurosurg Rev 1992; 15 (1) 33-36
59 van Loon J, Van Calenbergh F, Goffin J, Plets C. Controversies in the management of spontaneous cerebellar haemorrhage. A consecutive series of 49 cases and review of the literature. Acta Neurochir (Wien) 1993; 122 (3–4) 187-193
60 Kobayashi S, Sato A, Kageyama Y, Nakamura H, Watanabe Y, Yamaura A. Treatment of hypertensive cerebellar hemorrhage—surgical or conservative management?. Neurosurgery 1994; 34 (2) 246-250 , discussion 250–251
61 Morgenstern LB, Hemphill III JC, Anderson C , et al; American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41 (9) 2108-2129
62 Mendelow AD, Gregson BA, Fernandes HM , et al; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365 (9457) 387-397
63 Dey M, Stadnik A, Awad IA. Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials. Neurosurgery 2014; 74 (Suppl. 01) S142-S150
64 Takeuchi S, Wada K, Nagatani K, Otani N, Mori K. Decompressive hemicraniectomy for spontaneous intracerebral hemorrhage. Neurosurg Focus 2013; 34 (5) E5
65 Wang WZ, Jiang B, Liu HM , et al. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke 2009; 4 (1) 11-16
66 Naff NJ, Hanley DF, Keyl PM , et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004; 54 (3) 577-583 , discussion 583–584
67 Basaldella L, Marton E, Fiorindi A, Scarpa B, Badreddine H, Longatti P. External ventricular drainage alone versus endoscopic surgery for severe intraventricular hemorrhage: a comparative retrospective analysis on outcome and shunt dependency. Neurosurg Focus 2012; 32 (4) E4
68 Chen CC, Liu CL, Tung YN , et al. Endoscopic surgery for intraventricular hemorrhage (IVH) caused by thalamic hemorrhage: comparisons of endoscopic surgery and external ventricular drainage (EVD) surgery. World Neurosurg 2011; 75 (2) 264-268
69 Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ. Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology 2002; 59 (2) 205-209
70 Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63 (6) 1059-1064
71 Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998; 29 (6) 1160-1166
72 Hemphill III JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32 (4) 891-897
73 Hemphill III JC, Farrant M, Neill Jr TA. Prospective validation of the ICH Score for 12-month functional outcome. Neurology 2009; 73 (14) 1088-1094
74 Rost NS, Smith EE, Chang Y , et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke 2008; 39 (8) 2304-2309
75 Becker KJ, Baxter AB, Cohen WA , et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology 2001; 56 (6) 766-772
76 Goldstein JN, Thomas SH, Frontiero V , et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 2006; 37 (1) 151-155
77 Holbrook A, Schulman S, Witt DM , et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e152S-e184S
78 Fredriksson K, Norrving B, Strömblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992; 23 (7) 972-977
79 Adult intracerebral hemorrhage. 2009. Available from: http://www2.massgeneral.org/stopstroke/protocolAdultHemorrhage.aspx . Accessed February 10, 2015
80 Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 2008; 47 (5) 285-295
81 Pollack Jr CV, Reilly PA, Eikelboom J , et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015;
82 Mo Y, Yam FK. Recent advances in the development of specific antidotes for target-specific oral anticoagulants. Pharmacotherapy 2015; 35 (2) 198-207
83 Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011; 124 (14) 1573-1579